Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change

JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.

Correction to: A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression by Nayak, et al. Psychedelic Med 2023;1(1):18–26; doi: 10.1089/psymed.2022.0002

Psychedelic Medicine May 3, 2024 correction DOI: 10.1089/psymed.2022.0002.correx (opens in new tab) via OpenAlex

Relevant Not relevant

Summary

AI-generated from the abstract

This is a correction notice for a previously published article. It provides no new findings, arguments, or data.

Study at a glance

Topics	Anxiety Psilocybin
Keywords	Escitalopram Psychology Depression economics Psychiatry

Abstract

[This corrects the article DOI: 10.1089/psymed.2022.0002.].

Explore topics

Anxiety Psilocybin

Comments

No comments yet.

Log in to comment